Tg Therapeutics 15min Chart Triggers Bollinger Bands Narrowing, KDJ Death Cross Alert

Tg Therapeutics's 15-minute chart is currently exhibiting Bollinger Bands Narrowing, with a KDJ Death Cross signal set to occur on August 11th, 2025 at 12:30. This indicates that the magnitude of stock price fluctuations is decreasing, and momentum is shifting towards the downside with potential for further decreases in stock price.

Tg Therapeutics Inc. (NASDAQ: TGTX), a biopharmaceutical innovator specializing in B-cell malignancies and autoimmune disorders, has seen its stock exhibit a notable technical pattern on its 15-minute chart. The Bollinger Bands, a technical indicator that measures volatility, have been narrowing, indicating a decrease in the magnitude of price fluctuations. Additionally, a KDJ Death Cross signal is set to occur on August 11, 2025, at 12:30, suggesting a potential shift in momentum towards the downside.

Bollinger Bands Narrowing

The narrowing of the Bollinger Bands signals a decrease in volatility, which can indicate a period of consolidation or a potential trend reversal. This technical indicator is formed by plotting two standard deviations above and below a simple moving average of the price, and its width can provide insights into the stock's volatility. A narrowing of the bands suggests that the stock price is moving within a more confined range, which can be a precursor to a breakout in either direction.

KDJ Death Cross Signal

The KDJ Death Cross is a technical signal that occurs when the K line (a moving average of the price) crosses below the D line (a moving average of the K line). This signal is often considered a bearish indicator, suggesting that the price momentum is shifting towards the downside. When combined with the narrowing Bollinger Bands, this signal can reinforce the idea that a potential downtrend may be imminent.

Implications for Investors

For investors, the narrowing Bollinger Bands and the upcoming KDJ Death Cross signal provide a cautionary note. While these technical indicators do not guarantee a price movement, they can help in making informed decisions. Investors should consider these signals in conjunction with the company's fundamental performance and other technical indicators to assess the overall risk and potential for the stock.

Recent Financial Performance

In recent quarters, Tg Therapeutics has reported strong financial performance. For example, in Q2 2025, the company reported total revenue of $141.1 million, with BRIUMVI U.S. net revenue reaching $138.8 million, representing a 91% year-over-year growth. The company also raised its full-year 2025 guidance, targeting BRIUMVI U.S. net revenue of $570-575 million and total global revenue of approximately $585 million [2].

Conclusion

The narrowing Bollinger Bands and the upcoming KDJ Death Cross signal on Tg Therapeutics' 15-minute chart suggest a potential shift in momentum towards the downside. However, investors should not rely solely on these technical indicators. It is essential to consider the company's fundamental performance and other factors before making investment decisions.

References

[1] https://www.ainvest.com/news/lantern-expands-ai-radiology-platform-mammography-pet-ct-viewers-2508/
[2] https://www.stocktitan.net/news/TGTX/